(19)
(11) EP 2 475 254 A1

(12)

(43) Date of publication:
18.07.2012 Bulletin 2012/29

(21) Application number: 10816134.0

(22) Date of filing: 10.09.2010
(51) International Patent Classification (IPC): 
A01N 43/36(2006.01)
A61K 31/40(2006.01)
(86) International application number:
PCT/US2010/048377
(87) International publication number:
WO 2011/031934 (17.03.2011 Gazette 2011/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 11.09.2009 US 241577 P
11.09.2009 US 241617 P
11.09.2009 US 241595 P
11.09.2009 US 241489 P
11.09.2009 US 241578 P

(71) Applicant: Enanta Pharmaceuticals, Inc.
Watertown, MA 02472 (US)

(72) Inventors:
  • QIU, Yao-ling
    Andover MA 01810 (US)
  • WANG, Ce
    Waltham MA 02451 (US)
  • YING, Lu
    Shanghai 200331 (CN)
  • PENG, Xiaowen
    Auburndale MA 02466 (US)
  • OR, Yat, Sun
    Watertown MA 02472 (US)

(74) Representative: Chapman, Paul William et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) HEPATITIS C VIRUS INHIBITORS